Analysis of cell and protein deposits on the Impella Heart Pump.

Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

Heart Failure

Heart Conditions

Heart and lung conditions

The Impella heart pump supports patients in cardiogenic shock for various reasons and has
passed safety and biocompatibility evaluations. The planned investigation aims to further
analyze cell and protein adhesion on these pumps and the effects of their prolonged use,
especially in scenarios like bridge-to-transplant, recognizing preclinical testing
limitations.

Abiomed Impella Pump Return Registry - Observational Study

investigate Impella CP after use regarding deposits and biomaterial

investigate Impella 5.5 pumps after use regarding deposits and biomaterial

By correlating patient data, such as medical history and Impella CP related blood
parameters, with the findings from our pump analysis, potential connections between
medication, diseases, comorbidities, and deposits on the pump can be identified.

By correlating patient data, such as medical history and Impella 5.5 related blood
parameters, with the findings from our pump analysis, potential connections between
medication, diseases, comorbidities, and deposits on the pump can be identified.

Patients treated with Impella CP heart pump for more than 4 days due to severe acute
heart failure by any cause

Patients treated with Impella 5.5 heart pump for more than or equal to 25 days due to
severe acute heart failure by any cause

Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

Trials at a glance

Trials at a glance

Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

Outcome measures

Primary outcome measures

Secondary outcome measures